Characterization of Mycophenolate Mofetil Gastrointestinal Toxicity and Risk Factors for Severe Disease and Poor Prognosis
Open Access
- 18 November 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 28 (5) , 811-814
Abstract
Lay Summary: Authors performed a chart review to identify cases of mycophenolate mofetil gastrointestinal toxicity at our institution. In this cohort, friability was associated with severe disease; and nausea and erythema were associated with poor prognosis.Keywords
Funding Information
- National Institutes of Health
This publication has 10 references indexed in Scilit:
- Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation2015
- Clinicopathologic features and outcome of mycophenolate‐induced colitis in renal transplant recipientsClinical Transplantation, 2014
- Histological spectrum of mycophenolate mofetil‐related colitis: association with apoptosisHistopathology, 2013
- Microscopic features associated with mycophenolate mofetil in gastric and colonic biopsiesHistopathology, 2012
- Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetilLaboratory Investigation, 2009
- Crohn's‐like changes in the colon due to mycophenolate?Colorectal Disease, 2004
- Histologic Features of Mycophenolate Mofetil-Related Colitis: A Graft-Versus-Host Disease-Like PatternInternational Journal of Surgical Pathology, 2003
- Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.2003
- Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: relationship with corticosteroid dosage, renal function, sex, and patient ageTransplantation Proceedings, 1999
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987